Literature DB >> 29155721

Visualizing Macrophage Extracellular Traps Using Confocal Microscopy.

Roleen Sharma1, Kim M O'Sullivan2, Stephen R Holdsworth2, Philip G Bardin1, Paul T King3.   

Abstract

A primary method used to define the presence of neutrophil extracellular traps (NETs) is confocal microscopy. We have modified established confocal microscopy methods to visualize macrophage extracellular traps (METs). These extracellular traps are defined by the presence of extracellular chromatin with co-expression of other components such as granule proteases, citrullinated histones, and peptidyl arginase deiminase (PAD). The expression of METs is generally measured after exposure to a stimulus and compared to un-stimulated samples. Samples are also included for background and isotype control. Cells are analyzed using well-defined image analysis software. Confocal microscopy may be used to define the presence of METs both in vitro and in vivo in lung tissue.

Mesh:

Year:  2017        PMID: 29155721      PMCID: PMC5752424          DOI: 10.3791/56459

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  16 in total

1.  Neutrophil extracellular traps kill bacteria.

Authors:  Volker Brinkmann; Ulrike Reichard; Christian Goosmann; Beatrix Fauler; Yvonne Uhlemann; David S Weiss; Yvette Weinrauch; Arturo Zychlinsky
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

2.  Statins enhance formation of phagocyte extracellular traps.

Authors:  Ohn A Chow; Maren von Köckritz-Blickwede; A Taylor Bright; Mary E Hensler; Annelies S Zinkernagel; Anna L Cogen; Richard L Gallo; Marc Monestier; Yanming Wang; Christopher K Glass; Victor Nizet
Journal:  Cell Host Microbe       Date:  2010-11-18       Impact factor: 21.023

3.  Renal participation of myeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis.

Authors:  Kim M O'Sullivan; Camden Y Lo; Shaun A Summers; Kirstin D Elgass; Paul J McMillan; Anthony Longano; Sharon L Ford; Poh-Yi Gan; Peter G Kerr; A Richard Kitching; Stephen R Holdsworth
Journal:  Kidney Int       Date:  2015-07-15       Impact factor: 10.612

4.  Therapeutic Targeting of the IL-6 Trans-Signaling/Mechanistic Target of Rapamycin Complex 1 Axis in Pulmonary Emphysema.

Authors:  Saleela M Ruwanpura; Louise McLeod; Lovisa F Dousha; Huei J Seow; Sultan Alhayyani; Michelle D Tate; Virginie Deswaerte; Gavin D Brooks; Steven Bozinovski; Martin MacDonald; Christoph Garbers; Paul T King; Philip G Bardin; Ross Vlahos; Stefan Rose-John; Gary P Anderson; Brendan J Jenkins
Journal:  Am J Respir Crit Care Med       Date:  2016-12-15       Impact factor: 21.405

5.  Novel cell death program leads to neutrophil extracellular traps.

Authors:  Tobias A Fuchs; Ulrike Abed; Christian Goosmann; Robert Hurwitz; Ilka Schulze; Volker Wahn; Yvette Weinrauch; Volker Brinkmann; Arturo Zychlinsky
Journal:  J Cell Biol       Date:  2007-01-08       Impact factor: 10.539

6.  Inhibition of PAD4 activity is sufficient to disrupt mouse and human NET formation.

Authors:  Huw D Lewis; John Liddle; Jim E Coote; Stephen J Atkinson; Michael D Barker; Benjamin D Bax; Kevin L Bicker; Ryan P Bingham; Matthew Campbell; Yu Hua Chen; Chun-Wa Chung; Peter D Craggs; Rob P Davis; Dirk Eberhard; Gerard Joberty; Kenneth E Lind; Kelly Locke; Claire Maller; Kimberly Martinod; Chris Patten; Oxana Polyakova; Cecil E Rise; Martin Rüdiger; Robert J Sheppard; Daniel J Slade; Pamela Thomas; Jim Thorpe; Gang Yao; Gerard Drewes; Denisa D Wagner; Paul R Thompson; Rab K Prinjha; David M Wilson
Journal:  Nat Chem Biol       Date:  2015-01-26       Impact factor: 15.040

7.  Nontypeable Haemophilus influenzae induces sustained lung oxidative stress and protease expression.

Authors:  Paul T King; Roleen Sharma; Kim O'Sullivan; Stavros Selemidis; Steven Lim; Naghmeh Radhakrishna; Camden Lo; Jyotika Prasad; Judy Callaghan; Peter McLaughlin; Michael Farmer; Daniel Steinfort; Barton Jennings; James Ngui; Bradley R S Broughton; Belinda Thomas; Ama-Tawiah Essilfie; Michael Hickey; Peter W Holmes; Philip Hansbro; Philip G Bardin; Stephen R Holdsworth
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

8.  Mycobacterium tuberculosis exploits human interferon γ to stimulate macrophage extracellular trap formation and necrosis.

Authors:  Ka-Wing Wong; Williams R Jacobs
Journal:  J Infect Dis       Date:  2013-03-08       Impact factor: 5.226

9.  NET balancing: a problem in inflammatory lung diseases.

Authors:  Olivia Z Cheng; Nades Palaniyar
Journal:  Front Immunol       Date:  2013-01-24       Impact factor: 7.561

10.  Activation of PAD4 in NET formation.

Authors:  Amanda S Rohrbach; Daniel J Slade; Paul R Thompson; Kerri A Mowen
Journal:  Front Immunol       Date:  2012-11-29       Impact factor: 7.561

View more
  5 in total

Review 1.  Extracellular Trap by Blood Cells: Clinical Implications.

Authors:  R J Nija; S Sanju; Neeraj Sidharthan; Ullas Mony
Journal:  Tissue Eng Regen Med       Date:  2020-02-29       Impact factor: 4.169

2.  Macrolets: Outsized Extracellular Vesicles Released from Lipopolysaccharide-Stimulated Macrophages that Trap and Kill Escherichia coli.

Authors:  Wei Ding; Olivia C Rivera; Shannon L Kelleher; David I Soybel
Journal:  iScience       Date:  2020-05-05

Review 3.  Significance of Mast Cell Formed Extracellular Traps in Microbial Defense.

Authors:  Daniel Elieh Ali Komi; Wolfgang M Kuebler
Journal:  Clin Rev Allergy Immunol       Date:  2021-05-22       Impact factor: 8.667

Review 4.  Macrophage Extracellular Traps: Current Opinions and the State of Research regarding Various Diseases.

Authors:  Weizhen Weng; Zuoyu Hu; Yunfeng Pan
Journal:  J Immunol Res       Date:  2022-01-07       Impact factor: 4.818

5.  Streptococcus agalactiae Induces Placental Macrophages To Release Extracellular Traps Loaded with Tissue Remodeling Enzymes via an Oxidative Burst-Dependent Mechanism.

Authors:  David M Aronoff; Jennifer A Gaddy; Ryan S Doster; Jessica A Sutton; Lisa M Rogers
Journal:  mBio       Date:  2018-11-20       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.